# WHO Drug Study for Buruli Ulcer - Comparison of SR8 and CR8

> **NCT01659437** · PHASE2,PHASE3 · COMPLETED · sponsor: **University Medical Center Groningen** · enrollment: 310 (actual)

## Conditions studied

- Mycobacterium Ulcerans Infection

## Interventions

- **DRUG:** Clarithromycin Extended Release
- **DRUG:** Streptomycin intramuscular injection

## Key facts

- **NCT ID:** NCT01659437
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2017-12
- **Final completion:** 2018-01
- **Target enrollment:** 310 (ACTUAL)
- **Last updated:** 2019-09-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01659437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01659437, "WHO Drug Study for Buruli Ulcer - Comparison of SR8 and CR8". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01659437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*